Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity

Cisplatin is chemotherapy used for solid tumor treatment like lung, bladder, head and neck, ovarian and testicular cancers. However, cisplatin-induced ototoxicity limits the utility of this agent in cancer patients, especially when dose escalations are needed. Ototoxicity is associated with cochlear...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Aameri, Raheem F. H., Alanisi, Entkhab M. A., Oluwatosin, Adu, Al Sallami, Dheyaa, Sheth, Sandeep, Alberts, Ian, Patel, Shree, Rybak, Leonard P., Ramkumar, Vickram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102581/
https://www.ncbi.nlm.nih.gov/pubmed/37063917
http://dx.doi.org/10.3389/fimmu.2023.1125948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102581/
https://www.ncbi.nlm.nih.gov/pubmed/37063917
http://dx.doi.org/10.3389/fimmu.2023.1125948

Ejemplares similares